Partnerships

>

Latest News

Avadel Partners with XWPharma to Commercialize Sleep Medication
Avadel Partners with XWPharma to Commercialize Sleep Medication

September 4th 2025

The deal gives Avadel global rights to develop and market valiloxybate for narcolepsy and idiopathic hypersomnia, with a once-at-bedtime, sodium-free formulation designed to improve patient convenience and outcomes.

Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration

August 26th 2025

Boehringer Ingelheim, AnGes Ink Deal to Produce Next-Generation PAD Gene Therapy
Boehringer Ingelheim, AnGes Ink Deal to Produce Next-Generation PAD Gene Therapy

August 21st 2025

Skyhawk Therapeutics, Merck KGaA Strike Multi-Billion Dollar Deal to Advance RNA Therapies in Neurology
Skyhawk Therapeutics, Merck KGaA Strike Multi-Billion Dollar Deal to Advance RNA Therapies in Neurology

August 19th 2025

CIT Therapeutics and Institute for Follicular Lymphoma Innovation Launch Multimillion Dollar Partnership to Advance Cancer Therapy
CIT Therapeutics and Institute for Follicular Lymphoma Innovation Launch Multimillion Dollar Partnership to Advance Cancer Therapy

August 13th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.